461 related articles for article (PubMed ID: 21712015)
1. Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.
Wen MM
Discov Med; 2011 Jun; 11(61):497-503. PubMed ID: 21712015
[TBL] [Abstract][Full Text] [Related]
2. Insights into direct nose to brain delivery: current status and future perspective.
Mittal D; Ali A; Md S; Baboota S; Sahni JK; Ali J
Drug Deliv; 2014 Mar; 21(2):75-86. PubMed ID: 24102636
[TBL] [Abstract][Full Text] [Related]
3. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
4. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
5. Is nose-to-brain transport of drugs in man a reality?
Illum L
J Pharm Pharmacol; 2004 Jan; 56(1):3-17. PubMed ID: 14979996
[TBL] [Abstract][Full Text] [Related]
6. Delivery of peptides to the brain: emphasis on therapeutic development.
Banks WA
Biopolymers; 2008; 90(5):589-94. PubMed ID: 18335425
[TBL] [Abstract][Full Text] [Related]
7. Intranasal Delivery of Proteins and Peptides in the Treatment of Neurodegenerative Diseases.
Meredith ME; Salameh TS; Banks WA
AAPS J; 2015 Jul; 17(4):780-7. PubMed ID: 25801717
[TBL] [Abstract][Full Text] [Related]
8. Identification of nose-to-brain homing peptide through phage display.
Wan XM; Chen YP; Xu WR; Yang WJ; Wen LP
Peptides; 2009 Feb; 30(2):343-50. PubMed ID: 19007831
[TBL] [Abstract][Full Text] [Related]
9. Intranasal delivery of therapeutic proteins for neurological diseases.
Malerba F; Paoletti F; Capsoni S; Cattaneo A
Expert Opin Drug Deliv; 2011 Oct; 8(10):1277-96. PubMed ID: 21619468
[TBL] [Abstract][Full Text] [Related]
10. Delivery of interferon-beta to the monkey nervous system following intranasal administration.
Thorne RG; Hanson LR; Ross TM; Tung D; Frey WH
Neuroscience; 2008 Mar; 152(3):785-97. PubMed ID: 18304744
[TBL] [Abstract][Full Text] [Related]
11. Delivery of peptide and protein drugs over the blood-brain barrier.
Brasnjevic I; Steinbusch HW; Schmitz C; Martinez-Martinez P;
Prog Neurobiol; 2009 Apr; 87(4):212-51. PubMed ID: 19395337
[TBL] [Abstract][Full Text] [Related]
12. Intranasal delivery of biologics to the central nervous system.
Lochhead JJ; Thorne RG
Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
[TBL] [Abstract][Full Text] [Related]
13. A new generation of neurobiological drugs engineered to overcome the challenges of brain drug delivery.
Boado RJ
Drug News Perspect; 2008 Nov; 21(9):489-503. PubMed ID: 19180267
[TBL] [Abstract][Full Text] [Related]
14. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
15. Colloidal carriers and blood-brain barrier (BBB) translocation: a way to deliver drugs to the brain?
Garcia-Garcia E; Andrieux K; Gil S; Couvreur P
Int J Pharm; 2005 Jul; 298(2):274-92. PubMed ID: 15896933
[TBL] [Abstract][Full Text] [Related]
16. Biopharmaceutical drug targeting to the brain.
Pardridge WM
J Drug Target; 2010 Apr; 18(3):157-67. PubMed ID: 20064077
[TBL] [Abstract][Full Text] [Related]
17. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
Begley DJ
Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
[TBL] [Abstract][Full Text] [Related]
18. Intranasal administration of interferon beta bypasses the blood-brain barrier to target the central nervous system and cervical lymph nodes: a non-invasive treatment strategy for multiple sclerosis.
Ross TM; Martinez PM; Renner JC; Thorne RG; Hanson LR; Frey WH
J Neuroimmunol; 2004 Jun; 151(1-2):66-77. PubMed ID: 15145605
[TBL] [Abstract][Full Text] [Related]
19. Differential receptor-mediated drug targeting to the diseased brain.
Rip J; Schenk GJ; de Boer AG
Expert Opin Drug Deliv; 2009 Mar; 6(3):227-37. PubMed ID: 19327042
[TBL] [Abstract][Full Text] [Related]
20. Delivery of galanin-like peptide to the brain: targeting with intranasal delivery and cyclodextrins.
Nonaka N; Farr SA; Kageyama H; Shioda S; Banks WA
J Pharmacol Exp Ther; 2008 May; 325(2):513-9. PubMed ID: 18270319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
